Biocause Pharmaceutical To Invest 300M Yuan Propylene Project
Hubei Biocause Pharmaceutical plans to invest 301.96 million yuan in propylene production, which uses the process of catalytic cracking of C4 olefin, reports China Securities Journal, citing a company filing.
Total investment includes 200.02 million yuan in construction costs and 101.94 million yuan for working capital.
Once the project is operational, it will annually yield 21,800 tons of propylene, 10,000 tons of propane and 120,000 tons of liquefied natural gas.
转载本网专稿请注明出处“中国纺织网”
编辑:纺织网
文章关键词: Biocause Pharmaceutical Propylene